www.patheon.com
Patheon is a leading provider of contract development and manufacturing services to the global pharmaceutical industry. Patheon's technologies and services range from pre-clinical development to manufacturing a full array of dosage forms.
Patheon signs commercialisation deal for OROS-based release products
Patheon Inc (TSX: PTI), a provider of drug development and manufacturing services to the international pharmaceutical industry, said it has signed agreements to commercialize two OROS technology controlled release products from their Cincinnati facility.
The first product will launch in late 2009 and the second is planned to launch in the third quarter of 2010. Further details were not disclosed.
OROS is a specialized drug delivery technology used to achieve the controlled release of active drug substances. When a patient swallows an OROS tablet, water is drawn into a specially formulated portion of the tablet which swells, exerting pressure on the tablet drug layer. This gentle pressure forces the active drug out through laser-drilled holes in the tablet, allowing for a gradual release of the active drug substance.



















